Further investigations using cardiomyocytes with SPEG knockout, the tamoxifen treatment mouse model, or an inducible heart-specific SPEG knockout/overexpression mouse model will be warranted in order to systematically delineate the exact mechanisms for genetic functional variants in female severe COVID-19 patients. The gene discussed is SPEG; the disease is COVID-19.